GRAIL, Inc. (GRAL) Financials
GRAL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 2.8 billion | 302.8 million |
| Dec. 31, 2025 | 2.9 billion | 344.2 million |
| Sept. 30, 2025 | 2.6 billion | 361.1 million |
| June 30, 2025 | 2.7 billion | 387.9 million |
GRAL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -87.5 million | 16.8 million |
| Dec. 31, 2025 | -63.0 million | -44.5 million |
| Sept. 30, 2025 | -63.6 million | 14.1 million |
| June 30, 2025 | -77.3 million | 14.2 million |
GRAL Net Income
No data available :(
GRAL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 823.1 million | 41.1 million | 51.0 million |
| Dec. 31, 2025 | 904.4 million | 43.1 million | 43.1 million |
| Sept. 30, 2025 | 540.1 million | - | 58.6 million |
| June 30, 2025 | 602.8 million | - | 62.2 million |
GRAL Shares Outstanding
GRAL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 503000 | 48.0 million | 73.4 million | 30.7 million |
| Dec. 31, 2025 | 815000 | 46.9 million | 66.4 million | 27.7 million |
| Sept. 30, 2025 | 384000 | 48.6 million | 62.9 million | 25.5 million |
| June 30, 2025 | 369000 | 46.6 million | 66.5 million | 28.5 million |
GRAL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 40.8 million | 21.2 million |
| Dec. 31, 2025 | 43.6 million | 54.7 million |
| Sept. 30, 2025 | 36.2 million | 49.9 million |
| June 30, 2025 | 35.5 million | 53.3 million |
GRAL
Price: $61.13
52 week price:
Earnings Per Share: -10.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 2.6 billion